pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

7,883 catalysts · 5,256 phase readout · 2,309 8k filing · 315 pdufa · 259 earnings · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 0 catalysts2026-07-30: 38 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 13 catalysts2026-08-05: 16 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 1 catalyst2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 1 catalyst2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type
  • phase readout5,256
  • 8k filing2,309
  • pdufa315
  • earnings259
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›RECRUITINGphase readoutNCT07077967: Luminous Efficiency Function V(λ)' of Patients That Underwent Pseudophakic Presbyopic Corrections With EDOF IOLs

Sponsor: Democritus University of Thrace. Phase: . Conditions: Presbyopia

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06546800: SPECIAL INVESTIGATION FOR ABRYSVO IN INDIVIDUALS AGED 60 YEARS OR OLDER

Sponsor: Pfizer. Phase: . Conditions: Respiratory Syncytial Virus Infection

full page →ctgov ↗
›RECRUITINGphase readoutNCT05031507: Study of Skeletal Disorders

Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). Phase: . Conditions: Skeletal Disorders

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07550907: The Impact of Surgical Procedures on Postoperative Outcomes in Cataract Phacoemulsification and Analysis of Related Factors

Sponsor: Zhongshan Ophthalmic Center, Sun Yat-sen University. Phase: . Conditions: Age-related Cataract

full page →ctgov ↗
›WITHDRAWNphase readoutNCT07180602: Healing Minds II: Biofeedback, Breathing Practices, Nutrition and Exercise Counseling in Children and Adolescents With ADHD

Sponsor: Hoskinson Health and Wellness Clinic. Phase: NA. Conditions: Attention Deficit Disorder With Hyperactivity (ADHD)

full page →ctgov ↗
›RECRUITINGphase readoutNCT06844045: Point of Care STI Testing

Sponsor: Icahn School of Medicine at Mount Sinai. Phase: NA. Conditions: Point of Care STI Testing

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07552272: Hummingbird ICE Study

Sponsor: Philips Clinical & Medical Affairs Global. Phase: . Conditions: ATRIAL APPENDAGE CLOSURE for ATRIAL FIBRILLATION, Atrial Fibrillation (AF), Valve Disease, Heart, Atrial Septal Defect, Patent Foramen Ovale, Tricuspid Valve Disease

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07525895: Effect of Sciatic Nerve Mobilization on Lower Extremity Pain Perception

Sponsor: Fenerbahce University. Phase: NA. Conditions: Sciatic Nerve, Lower Extremity Pain

full page →ctgov ↗
›RECRUITINGphase readoutNCT07322939: Effects of Exercise With Visual Feedback in Parkinson's Disease

Sponsor: Hasan Kalyoncu University. Phase: NA. Conditions: Parkinson Disease, Balance Impairment, Exercise Training, Postural Control

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT03463239: Bioengineered Penile Tissue Constructs for Irreversibly Damaged Penile Corpora

Sponsor: Wake Forest University Health Sciences. Phase: PHASE1. Conditions: Urologic Diseases, Male Urogenital Diseases, Penile Diseases, Corpus Callosum Malformation, Corpora Cavernosa; Inflammation, Trauma Injury

full page →ctgov ↗
›COMPLETEDphase readoutNCT04362839: Regorafenib, Ipilimumab and Nivolumab for the Treatment of Chemotherapy Resistant Microsatellite Stable Metastatic Colorectal Cancer

Sponsor: City of Hope Medical Center. Phase: PHASE1. Conditions: Advanced Colon Adenocarcinoma, Metastatic Colon Adenocarcinoma, Metastatic Colorectal Adenocarcinoma, Metastatic Colorectal Carcinoma, Metastatic Rectal Adenocarcinoma, Stage III Colon Cancer AJCC v8, Stage III Rectal Cancer AJCC v8, Stage IIIA Colon Cancer AJCC v8, Stage IIIA Rectal Cancer AJCC v8, Stage IIIB Colon Cancer AJCC v8, Stage IIIB Rectal Cancer AJCC v8, Stage IIIC Colon Cancer AJCC v8, Stage IIIC Rectal Cancer AJCC v8, Stage IV Colon Cancer AJCC v8, Stage IV Colorectal Cancer AJCC v8, Stage IV Rectal Cancer AJCC v8, Stage IVA Colon Cancer AJCC v8, Stage IVA Colorectal Cancer AJCC v8, Stage IVA Rectal Cancer AJCC v8, Stage IVB Colon Cancer AJCC v8, Stage IVB Colorectal Cancer AJCC v8, Stage IVB Rectal Cancer AJCC v8, Stage IVC Colon Cancer AJCC v8, Stage IVC Colorectal Cancer AJCC v8, Stage IVC Rectal Cancer AJCC v8

full page →ctgov ↗
›COMPLETEDphase readoutNCT07329439: Comparative Effects of High Intensity and Eccentric Resistance Among School Going Basketball Players

Sponsor: Riphah International University. Phase: NA. Conditions: Basketball

full page →ctgov ↗
›COMPLETEDphase readoutNCT04139057: EBV-Specific Anti-PD1 TCR-T Cells in the Treatment of EBV-Positive NHSCC

Sponsor: Xinqiao Hospital of Chongqing. Phase: PHASE1. Conditions: Head and Neck Squamous Cell Carcinoma

full page →ctgov ↗
›COMPLETEDphase readoutNCT05034081: Impact Of Post-Bariatric Body Contouring Procedures on Patient Body Weight and Metabolism

Sponsor: Assiut University. Phase: NA. Conditions: Bariatric Surgery Candidate

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04645381: Bone Erosions in Rheumatoid Arthritis - Characterization Evaluated by Imaging and Histology

Sponsor: University of Aarhus. Phase: . Conditions: Arthritis, Rheumatoid

full page →ctgov ↗
›RECRUITINGphase readoutNCT07384481: Building Core Competencies of Taiwanese Care Food Specialists: Curriculum Design and Outcome Assessment

Sponsor: Chang Gung Memorial Hospital. Phase: NA. Conditions: Healthy

full page →ctgov ↗
›COMPLETEDphase readoutNCT07383181: Standing vs. Squatting Positions During Labor

Sponsor: Biruni University. Phase: NA. Conditions: Labor Position and Maternal Birth Experience

full page →ctgov ↗
›COMPLETEDphase readoutNCT03516201: Oral Health in Bariatric Patients

Sponsor: University of Göttingen. Phase: . Conditions: Adiposity, Dental Diseases, Bariatric Surgery Candidate

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07568912: Frailty and Intraoperative Hypoxemia Risk in Elderly ERCP Patients

Sponsor: China-Japan Friendship Hospital. Phase: . Conditions: Hypoxemia

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07337330: Ultrasound Guided External Oblique Intercostal Plane Block Versus Erector Spinae Block for Post Hepatectomy Pain

Sponsor: National Cancer Institute, Egypt. Phase: NA. Conditions: Pain; Cancer, Hepatectomy, Nerve Block

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07529665: Efficacy of Immersive Virtual Reality Combined With Stationary Cycling on Gait in Individuals With Stroke

Sponsor: University of Cadiz. Phase: NA. Conditions: Stroke

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07562607: Clinical Evaluation of AI-Generated Dental Crowns

Sponsor: The University of Hong Kong. Phase: NA. Conditions: Tooth Defect

full page →ctgov ↗
›RECRUITINGphase readoutNCT07282600: A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

Sponsor: Eli Lilly and Company. Phase: PHASE3. Conditions: Overweight, Obesity

full page →ctgov ↗
›RECRUITINGphase readoutNCT06916936: Effect of Peanut Butter on Gut and Metabolic Health

Sponsor: Florida State University. Phase: NA. Conditions: Dysbiosis

full page →ctgov ↗
›RECRUITINGphase readoutNCT04907136: Developing and Testing Health Warning Labels on the ENDS Device

Sponsor: Florida International University. Phase: NA. Conditions: Electronic Cigarette Use

full page →ctgov ↗
›RECRUITINGphase readoutNCT05208944: THIO Sequenced With Cemiplimab in Advanced NSCLC

Sponsor: Maia Biotechnology. Phase: PHASE2. Conditions: Carcinoma, Non-Small-Cell Lung

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07554144: The Effect of Body Percussion Training on Neuromotor Performance, Attention, and Functionality in Adolescents With Mild Intellectual Disability

Sponsor: Kutahya Health Sciences University. Phase: NA. Conditions: Mild Cognitive Impairment, Attention Impaired, Adolescent Development

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05375344: Mobility and Voiding Exercises in Older Women With Urinary Incontinence (MoVEonUp)

Sponsor: University of Pennsylvania. Phase: NA. Conditions: Urinary Incontinence, Urge

full page →ctgov ↗
›RECRUITINGphase readoutNCT07215234: A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration

Sponsor: Sanofi. Phase: PHASE1. Conditions: Geographic Atrophy

full page →ctgov ↗
›RECRUITINGphase readoutNCT05776771: The Spine Phenome Project

Sponsor: Ohio State University. Phase: . Conditions: Low Back Pain, Neck Pain

full page →ctgov ↗
›RECRUITINGphase readoutNCT06968871: Ameliorated Pap Tests and Cervical Cancer Screening Participation

Sponsor: National Taiwan University Hospital. Phase: NA. Conditions: Cervical Cancer Screening, Cervical Cancer Screening Methods

full page →ctgov ↗
›RECRUITINGphase readoutNCT01866371: High Resolution Retinal Imaging

Sponsor: University of Pennsylvania. Phase: . Conditions: Stargardts, Retinitis Pigmentosa, Age-related Macular Degeneration, Choroideremia, Geographic Atrophy

full page →ctgov ↗
›RECRUITINGphase readoutNCT06803771: Surveillance of Pancreatic Health After Diabetes Diagnosis

Sponsor: University Hospital Southampton NHS Foundation Trust. Phase: NA. Conditions: Diabetes Mellitus, Pancreatic Cancer, Adult

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04704934: Trastuzumab Deruxtecan for Subjects With HER2-Positive Gastric Cancer or Gastro-Esophageal Junction Adenocarcinoma After Progression on or After a Trastuzumab-Containing Regimen (DESTINY-Gastric04)

Sponsor: Daiichi Sankyo. Phase: PHASE3. Conditions: Gastric Cancer, Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT06622434: New Adjuvant Vaccine in Glioblastoma, a Phase 1/2a Study

Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: PHASE1. Conditions: Newly Diagnosed Glioblastoma

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07433842: Surgery-First Orthognathic Surgery in Skeletal Class III Treatment

Sponsor: Hanoi Medical University. Phase: NA. Conditions: Skeletal Class III Malocclusion

full page →ctgov ↗
›RECRUITINGphase readoutNCT07472686: Small Bowel Capsule Endoscopy in Lynch Syndrome

Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: . Conditions: MMR Mutation, Small Bowel Adenoma, Small-bowel Adenocarcinoma, Lynch Syndrome, Cancer

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04370483: Leflunomide for the Treatment of High-Risk Smoldering Multiple Myeloma

Sponsor: City of Hope Medical Center. Phase: EARLY_PHASE1. Conditions: Smoldering Plasma Cell Myeloma

full page →ctgov ↗
›COMPLETEDphase readoutNCT02694783: Adoptive Cellular Immunotherapy for Progressive Multifocal Leukoencephalopathy With Ex Vivo Generated Polyomavirus-Specific T-Cells

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS). Phase: EARLY_PHASE1. Conditions: Progressive Multifocal Leukoencephalopathy

full page →ctgov ↗
›RECRUITINGphase readoutNCT04530383: Metformin for People With CFRD on CFTR Modulator Therapy to Improve Ion Channel Function

Sponsor: University of Kansas Medical Center. Phase: PHASE2. Conditions: Cystic Fibrosis-related Diabetes, Cystic Fibrosis

full page →ctgov ↗
›RECRUITINGphase readoutNCT03214354: Nonmyeloablative Stem Cell Transplant in Children With Sickle Cell Disease and a Major ABO-Incompatible Matched Sibling Donor

Sponsor: University of Calgary. Phase: PHASE2. Conditions: Sickle Cell Disease, Stem Cell Transplant Complications, Red Blood Cell Disorder, Pure Red Cell Aplasia

full page →ctgov ↗
›COMPLETEDphase readoutNCT07390305: Multidimensional Correlation Study on Skin Aging in Menopausal Women

Sponsor: ChinaNorm. Phase: . Conditions: Skin Aging, Reproductive Aging, Menopause, Genetic Factors

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07014605: Smoking Cessation Program for Lao People With HIV

Sponsor: University of Oklahoma. Phase: NA. Conditions: Smoking Cessation, HIV

full page →ctgov ↗
›RECRUITINGphase readoutNCT06441305: Expanding Coverage of Severe Acute Malnutrition (SAM) Treatment in Kenya

Sponsor: International Food Policy Research Institute. Phase: NA. Conditions: Acute Malnutrition, Severe, Malnutrition, Child, Wasting

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03484494: Low Field Magnetic Stimulation: Imaging Biomarkers in Geriatric Bipolar Depression

Sponsor: Mclean Hospital. Phase: NA. Conditions: Bipolar Disorder, Bipolar Depression, Bipolar I Disorder, Bipolar II Disorder

full page →ctgov ↗
›COMPLETEDphase readoutNCT06029894: Improving Sleep and AD Biomarkers

Sponsor: Emory University. Phase: NA. Conditions: Mild Cognitive Impairment, Alzheimer Disease

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04610866: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Long-term Mitapivat Dosing in Subjects With Stable Sickle Cell Disease: An Extension of a Phase I Pilot Study of Mitapivat

Sponsor: National Heart, Lung, and Blood Institute (NHLBI). Phase: PHASE1. Conditions: Sickle Cell Disease, Hemolytic Anemia

full page →ctgov ↗
›RECRUITINGphase readoutNCT07351851: Effects of PEMM in Chronic Low Back Pain Women With Urinary Incontinence

Sponsor: Hamad Medical Corporation. Phase: NA. Conditions: Chronic Low-back Pain (cLBP), Urinary Incontinence (UI), Pelvic External Myofascial Mobilisation, Myofascial Techniques, Pelvic Pain

full page →ctgov ↗
›RECRUITINGphase readoutNCT06044051: Dynamics of the Upper and Lower Airway Respiratory Microbiomes Associated With Severe Infant Asthma

Sponsor: University Hospital, Rouen. Phase: NA. Conditions: Asthma in Children, Asthma

full page →ctgov ↗
›RECRUITINGphase readoutNCT07333131: Identification of Iatrogenic Drug Events Upon Admission to the Adult Emergency Departments

Sponsor: University Hospital, Strasbourg, France. Phase: . Conditions: Iatrogenic Drug Events

full page →ctgov ↗
← prev
page 74 of 158
next →